Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Clinical Study of UF-021 for Retinitis Pigmentosa - Evaluation for a Comparative Double Masked Placebo Controlled Study Period and a Continuous Administration Period

NCT01786395 is registered in ClinicalTrials.gov with R-Tech Ueno, Ltd. as lead sponsor.

NCT NCT01786395
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01786395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Clinical Study of UF-021 for Retinitis Pigmentosa - Evaluation for a Comparative Double Masked Placebo Controlled Study Period and a Continuous Administration Period
Lead sponsor
R-Tech Ueno, Ltd.
Phase
Phase 3
Overall status
Terminated
Start date
March 31, 2013
Completion date
Not reported
Enrollment
202 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

retinitis pigmentosa